Flavopiridol, the First Cyclin-Dependent Kinase Inhibitor: Recent Advances in Combination Chemotherapy

By  

Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 11, 2010-10 ,pp. : 1058-1070

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclin-dependent kinase inhibitor therapy for hematologic malignancies

By Bose Prithviraj   Simmons Gary L   Grant Steven  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. : 723-738

Informa Healthcare

Access to resources Recommend Favorite

Phase II trial of flavopiridol, a cyclin dependent kinase inhibitor, in untreated metastatic malignant melanoma

By Burdette-Radoux Susan   Tozer Richard   Lohmann Reinhard   Quirt Ian   Ernst D.   Walsh Wendy   Wainman Nancy   Colevas A.   Eisenhauer Elizabeth  

Investigational New Drugs, Vol. 22, Iss. 3, 2004-08 ,pp. : 315-322

Springer Publishing Company

Access to resources Recommend Favorite

Cyclin-Dependent Kinase Inhibition by Flavoalkaloids

By  

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 7, 2012-06 ,pp. : 632-649

Bentham Science Publishers

Access to resources Recommend Favorite

The Cyclin-Dependent Kinase Inhibitor p21CDKN1A as a Target of Anti-Cancer Drugs

By  

Current Cancer Drug Targets, Vol. 12, Iss. 2, 2012-02 ,pp. : 85-96

Bentham Science Publishers

Access to resources Recommend Favorite